-
Posted by
Two Blokes Jul 21 -
Filed in
Stock
-
5 views
Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF) said it is gearing up for a busy year, as it reported stable revenue for the year to June 30. Updating on trading, it said it has submitted a marketing authorisation application for its Grass MATA MPL immunotherapy product and is preparing for a potential launch in the 2026 financial year.
